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Abstract Both histological and in vitro studies indicate a
relationship between T-cadherin levels and acquisition of
a modulated, migratory phenotype by vascular cells. This
study further examines a role for T-cadherin in relation to
cell migration and adhesion. Fluorescence microscopic
examination of T-cadherin localisation in confluent
cultures of human umbilical vein endothelial cells (HU-
VEC), human aortic smooth muscle cells and the human
carcinoma cell line ECV-304 revealed global distribution
over the entire cell body, and with only slight enrichment
at cell borders. This contrasts with restricted cell–cell
junction localisation of classical cadherin (for example,
VE-cadherin in HUVEC). In wounded cultures, T-
cadherin polarised to the leading edge of cells migrating
into the wound area, again contrasting with classical VE-
cadherin, which was undetectable in this region. Confocal
microscopy demonstrated that potential signalling func-
tions of T-cadherin at the leading edge are unrelated to
physical interactions with caveolin. Adherence of HU-
VEC onto a monolayer of T-cadherin-transfected L929
cells is significantly reduced compared with adhesion
onto control (T-cadherin-negative) L929. Thus T-cad-
herin is not required for maintenance of intercellular
adhesion, but may rather function as a signalling molecule
involved in cell–cell recognition and sensing of the
environment in processes where cell detachment occurs.
Keywords T-cadherin · Vascular cells · Fluorescence
microscopy · Migration · Adhesion · Caveolin
Introduction
Cadherins are cell surface glycoproteins that mediate
homophilic calcium-dependent intercellular adhesion
(Angst et al. 2001). The “classical” cadherins are
composed of five extracellular domains, the first extra-
cellular amino terminal domain bearing the binding site
for a homotypical cadherin on a neighbouring cell, a
transmembrane and a cytosolic domain which is linked to
actin cytoskeleton. T-cadherin (T-cad) is an atypical
member of the cadherin superfamily: while possessing the
general extracellular structure of the classical type I
cadherins, it lacks the transmembrane and cytoplasmic
domains and is bound to the plasma membrane via a
glycosylphosphatidylinositol anchor (Ranscht and Dours-
Zimmermann 1991; Vestal and Ranscht 1992). It is not
clear whether this truncated cell surface molecule,
obviously not directly linked to the cytoskeleton, can
mediate mechanical coupling of cells in vivo, although in
suspensions of transfected cells T-cad was shown to
mediate weak cell aggregation (Vestal and Ranscht 1992;
Niermann et al. 2000). The only physiological function of
T-cad proven so far is regulation of motor axon projection
in the embryonic nervous system via contact inhibition
mechanism (Fredette and Ranscht 1994; Fredette et al.
1996). The role for T-cad in the adult has been studied
mostly in tumours, where it was usually downregulated as
compared to normal tissue, while transfection of cancer
cells with T-cad cDNA decreased their proliferative and
invasive potential (reviewed in Takeuchi and Ohtsuki
2001). These data imply that T-cad is a signalling and
recognition receptor rather than a true adhesion molecule.
T-cadherin is highly expressed in the cardiovascular
system and is present on endothelial cells, pericytes and
smooth muscle cells from all layers of the vascular wall
(Ivanov et al. 2001; Kudrjashova et al. 2002). Histological
analysis of T-cad expression in diseased human vessels
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demonstrated that its level was markedly increased in
smooth muscle cells during atherosclerosis and restenosis
after percutaneous balloon angioplasty (Ivanov et al.
2001; Kudrjashova et al. 2002), and on endothelial cells
of tumour-penetrating vessels (Wyder et al. 2000). Since
these disorders are characterised by enhanced vascular
cell motility and growth (Schwartz 1997; Conway et al.
2001), upregulation of T-cad in atherosclerotic lesions,
restenotic tissue and angiogenic vessels is contrary to
what has been found in most tumour cells where an
increase in T-cad is associated with decreased cell growth
and invasion (Takeuchi and Ohtsuki 2001). We have
proposed that in vascular cells T-cad may contribute to
the acquisition of a less adhesive, promigratory cell
phenotype (Schwartz 1997; Conway et al. 2001).
In this study we have examined the role for T-cad in
relation to cell migration and adhesion in vitro. Since
directional cellular locomotion and adhesion–deadhesion
processes are thought to involve lateral transport/redistri-
bution of cell surface molecules we performed immuno-
cytochemical analysis of T-cad localisation in quiescent
and migrating cultures of human umbilical vein endothe-
lial cells and human aortic smooth muscle cells. T-cad
localisation was also studied in ECV-304 cells, a human
bladder carcinoma cell line (Dirks et al. 1999) which has
many endothelial features (Suda et al. 2001) and is widely
used as a model cell line for endothelia. We also
addressed whether elevation of surface T-cad expression
within a cell monolayer might affect the ability of other
cells to adhere to that monolayer.
Materials and methods
Cell culture
Human umbilical vein endothelial cells (HUVEC) and endothelial
cell growth medium containing endothelial cell growth supplement
were purchased from PromoCell (Heidelberg, Germany). HUVEC
at between passage 2 and 6 were used in the described experiments.
Human bladder carcinoma cell line ECV-304 was a kind gift of Dr.
V. Stepanova, Cardiology Research Center, Moscow. ECV-304
were cultured in Dulbecco’s modified essential medium (DMEM)
supplemented with 10% fetal calf serum (FCS), 10 mM TES/
HEPES (pH 7.3), 100 U/ml penicillin/streptomycin and 20 mM
Glutamax (Invitrogen, Basel, Switzerland). Human aortic smooth
muscle cells (hSMC) were isolated and phenotypically character-
ised in primary cultures as described previously (Scott-Burden et al.
1989) and cultured in DMEM supplemented as described above for
ECV-304 with addition of smooth muscle growth supplement
(Cascade Biologics, Portland, USA). For the experiments described
herein hSMC were used at between passage 6 and 13. Transformed
mouse fibroblast cell line L929 was cultured in DMEM supple-
mented as described for ECV-340.
Immunocytochemistry and microscopy
Cells were plated in 24-well plates onto round 12-mm glass
coverslips precoated with 0.1% gelatine at a density of
1.5105 cells/well. Confluent, quiescent monolayers were either
fixed with 4% paraformaldehyde immediately or wounded with a
scraper made of a bent needle (5 mm wide) and fixed after 18–24 h
incubation for analysis of migrating cells. After preincubation in
blocking solution (10% FCS in PBS) samples were processed for
single or double immunostaining. Polyclonal antibody against
recombinant amino terminal domain of human T-cad was raised in
our laboratory (Ivanov et al. 2001) and purified on affinity column
with immobilised recombinant domain coupled to CNBr-activated
Sepharose 4B (Amersham Pharmacia Biotech, Uppsala, Sweden).
The following commercially available antibodies were used:
monoclonal anti-VE-cadherin, monoclonal anti-caveolin (both
1:100; BD Transduction Laboratories, Heidelberg, Germany) and
secondary anti-species Cy-2- and Cy3-labelled IgG (both 1:500;
Jackson Immunoresearch Laboratories, West Grove, USA). For
controls, samples were incubated with non-immune mouse or rabbit
IgG as a substitute for primary antibodies. Nuclei were counter-
stained with Hoechst (1:3,000 in PBS; Molecular Probes, Leiden,
Netherlands), and slides were mounted upside-down in FluorSave
reagent (Calbiochem, Darmstadt, Germany). Single immunostained
samples were studied under a Zeiss Axiophot fluorescent micro-
scope (Zeiss, Feldbach, Switzerland), and photos were taken using
a digital camera and AnalySIS software (Soft Imaging System,
Munich, Germany). Double immunostained samples were exam-
ined using a laser scanning confocal microscope LSM 510 (Zeiss).
Images were processed and analysed for colocalisation on an O2
Workstation (Silicon Graphics Computer Systems, Mountain View,
CA, USA) using Imaris 3.0 and Colocalization Bitplanes software
(Bitplane, Zurich, Switzerland). Micrographs present typical
images.
Transfection of L929 cells with human T-cadherin
Full-size human T-cad cDNA was generated by RT-PCR using
mRNA from cultured human aortic smooth muscle cells as a
template. cDNA was cloned into pcDNA 3.1 vector (Invitrogen,
San Diego, USA) and used for transfection of L929 cells with
Lipofectin reagent (Invitrogen). Luciferase cDNA fragment in
antisense orientation was cloned into pcDNA 3.1 and used for
transfection as control vector. L929 clones carrying inserts were
selected by incubation in DMEM/10% FCS containing 200 mg/ml
Geniticin (Invitrogen) and tested for T-cad expression by immu-
noblotting and surface antibody binding with anti-T-cad antibodies
generated in our laboratory (see under Immunocytochemistry and
microscopy). The method of immunoblotting was fully described
previously (Kuzmenko et al. 1998). For surface binding transfected
L929 clones were seeded into 96-well plates and grown to
confluent monolayer. Then cells were washed with cold PBS and
incubated for 2 h at 4C with different concentrations of anti-T-cad
IgG or non-immune rabbit IgG diluted in PBS containing 3% BSA
and 10 mM HEPES pH 7.5. After washing, cells were incubated
with secondary horseradish peroxidase-conjugated goat anti-rabbit
IgG (1:2,500; Southern Biotechnology, Birmingham, USA) for 1 h.
Colour reaction was developed using Fast o-phenylenediamine
dihydrochloride tablet kit (Sigma-Aldrich Chemie, Steinheim,
Germany), and OD460 was measured in a SpectraMax 190
ELISA-reader (Bucher Biotec, Basel, Switzerland). T3 clone with
highest level of T-cad expression and two control clones E9 and
E15 were selected for further experiments.
ELIRA adhesion assay
T-cadherin-deficient and T-cad-expressing L929 cell clones were
seeded into 96-well plates and grown to confluent monolayer,
mildly fixed for 30 s with 0.1% paraformaldehyde and carefully
washed several times with PBS to remove all traces of parafor-
maldehyde. HUVEC were seeded (5,000 cells per well) on top of
the L929 monolayers in normal endothelial growth medium (see
under Cell culture). Adherent HUVEC were quantitated after 16 h
by ELIRA for von Willebrand factor: cells were washed, fixed with
4% paraformaldehyde, preblocked with PBS containing 3% BSA
for 30 min, incubated with anti-von Willebrand factor IgG (1:400;
Dako, Denmark) or non-immune rabbit IgG for 1 h and, after
washing, with secondary horseradish peroxidase-conjugated goat
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anti-rabbit IgG (1:2,500; Southern Biotechnology) for 1 h. Colour
reaction was developed using Fast o-phenylenediamine dihydro-
chloride tablet kit, and OD460 was measured in a SpectraMax 190
ELISA-reader. L929 monolayers without HUVEC served as
background controls.
Results
T-cadherin in vascular cells does not localise
to intercellular junctions in monolayer cultures
and concentrates at the leading edge in migrating cells
Immunofluorescence staining for T-cad in confluent
monolayers of cultured hSMC, HUVEC and ECV-304
revealed a global and punctuate localisation over the
entire cell body (Fig. 1A–D). Occasionally a mild
enrichment of T-cad at cell–cell borders was seen (see
within Fig. 1A or D). However, the generally diffuse
distribution of T-cad was quite distinct from that of VE-
cadherin (in HUVEC) which was restricted at cell–cell
borders in the pattern typical of classical cadherins
(Fig. 1E, F).
The distribution of T-cad in migrating cells was
examined after wounding of confluent cell monolayers
and images are presented in Fig. 2. Cells migrating into
the wound area displayed typical “migratory” appear-
ances, namely elongated and bearing pseudopods at the
leading edge with a rear-end protrusion in the case of
hSMC (Fig. 2A–C), and rather more ovally polarised with
a broad leading edge in the case of endothelial cells
(Fig. 2D–I). Immunofluorescent localisation of T-cad
revealed a distinct enrichment at the leading edge of
migrating hSMC (Fig. 2A–C), ECV-304 (Fig. 2D–F) and
HUVEC (Fig. 2G–I). VE-cadherin was never enriched at
the leading lamella in migrating HUVEC, and in fact was
barely detectable in single migrating cells (see, for
example, Fig. 2J). Images (Fig. 2K, L) of cells just
starting to protrude into the wound area from the rim of
the monolayer demonstrate the presence VE-cadherin
only at intercellular contacts and not at the leading edge.
Black-and-white contrast versions (Fig. 2M–O) of the
original fluorescence images (Fig. 2J–L) of VE-cadherin
in migrating HUVEC are presented to enable clear
visualisation of the cell body.
T-cadherin does not colocalise with caveolin
at the leading edge in migrating cells
Glycosylphosphatidylinositol (GPI)-proteins are known to
be associated with caveolae domains of the plasma
membrane (Harder and Simons 1997). Our previous
studies demonstrated that extracts of Triton-insoluble
plasmalemmal domains from human aortic media and
aortic SMC were enriched in T-cad together with other
GPI-proteins and caveolin (Philippova et al. 1998). Since
caveolin has been shown to be distributed to the leading
edge of migrating SMC (Okada et al. 1995), the polarised
distribution of T-cad observed in migrating cells might be
related to its interaction with caveolin. To address this
issue we performed double immunostaining for caveolin
and T-cad in migrating SMC and HUVEC and analysed
the samples by laser scanning confocal microscopy. In
total, 20 different images for each cell type were
analysed, of which 3 are presented in Fig. 3 as being
typically representative of cells either migrating already
some distance away from the wound edge (Fig. 3 panel
sets I and III) or cells in the process of migrating out of
the wound edge (Fig. 3 panel set II). Each image was
scanned and “dissected” into stacks of 200.5 mm hor-
izontal slices. Figure 3A–D shows the slice focused for
maximal T-cad staining at the leading edge, while
Fig. 3E–H shows another slice focused for maximal
caveolin staining. The double-channel (Fig. 3A, E) and
single-channel (Fig. 3B, C, F, G) images demonstrate that
while T-cad (red staining) can be detected at the leading
Fig. 1A–H Cadherin localisation in cell monolayers. Confluent
monolayers of human aortic smooth muscle cells (hSMC; A), ECV-
304 (B) and human umbilical vein endothelial cells (HUVEC; C–F)
were stained with antibodies against T-cadherin (T-cad; A–D) or
VE-cadherin (E, F). Nuclei were counterstained with Hoechst. G
Non-immune control for anti-T-cad antibody. H Non-immune
control for anti-VE-cadherin antibody. Bar length 20 mm
355
edge of moving cells, it is not always the case for caveolin
(green staining). In migrating SMC caveolin is found
either at the frontal cell periphery (Fig. 3 panel set I) or in
the perinuclear area (Fig. 3 panel set II), while in most
migrating HUVEC it can be detected only around the
nucleus and not at the leading edge.
Stringent colocalisation analysis (yellow colour) re-
vealed that caveolin and T-cad were not precisely
colocalised at the leading edge. Firstly, maximal edge
stainings for either of the proteins were always detected at
different depths (i.e. within different optical slices).
Secondly, image analysis with colocalisation software
consistently revealed a very poor degree of colocalisation
at the leading edge. In the colocalisation channel there
was an emergence of single occasional pixels that did not
form a consistent pattern; this random pixelation is an
Fig. 2A–O Cadherin localisa-
tion in migrating cells. Wound-
ed cultures of hSMC (A–C),
ECV-304 (D–F) and HUVEC
(G–L) were stained with anti-
bodies against T-cad (A–I) or
VE-cadherin (J–L). Nuclei
were counterstained with
Hoechst. Arrows show the di-
rection of cell migration. M–O
Contrasted black-and-white
versions of images J–L, re-
spectively. Bar length 20 mm
Fig. 3A–H Localisation of T-cad and caveolin in migrating
vascular cells: double immunostaining. Wounded cultures of hSMC
(panel sets I, II) and HUVEC (panel set III) were stained with
antibodies against T-cad (red staining) and caveolin (green
staining). Samples were analysed using confocal microscopy.
Typical images of three different cells are shown in panel sets I–
III. In each set A–D show the optical slice focused on maximal T-
cad staining at the leading edge, and E–H another slice focused on
maximal caveolin staining. A, E Double-channel fluorescence for
T-cad and caveolin. B, G Single-channel fluorescence for T-cad. C,
F Single-channel fluorescence for caveolin. D, H Colocalisation
pattern alone. Panel set IV Double-stained non-immune control.
Bar length 20 mm
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indication of random overlapping of colours but not of
true colocalisation (see Fig. 3D, H). Thirdly, even this
weak colocalisation pattern never coincided with patterns
of maximal edge staining for T-cad or caveolin (compare
Fig. 3D, H with single-channel staining for each of the
proteins). In contrast, a significant degree of T-cad and
caveolin colocalisation was frequently observed in the
more “central” part of the cell body, especially in the
perinuclear area (see for example, Fig. 3D, H panel sets II
and III).
Negative adhesive functions for T-cadherin
We also addressed whether elevation of surface T-cad
expression within a cell monolayer might affect the
ability of other cells to adhere to that monolayer. HUVEC
were seeded onto monolayers of L929 cells (which do not
express cadherin molecules (Chen and Obrink 1991; Van
Itallie and Anderson 1997; American Type Culture
Collection) transfected with human T-cad cDNA or
control vectors (see Fig. 4A for proof of expression and
appropriate surface location). Adhesion of HUVEC to
monolayers was assessed by ELIRA targeting endothelial
specific von Willebrand factor. We found that adhesion of
HUVEC onto T-cad-transfected L929 was reduced to
Fig. 4A, B Adhesion of HU-
VEC onto monolayers of L929
cells transfected with T-cad
cDNA. T-cad expression in
empty vector-transfected (E9
and E15) and human T-cad-
transfected (T3) L929 clones
was proven by immunoblotting
and surface antibody binding
(A). Partially purified T-cad
(pure Tcad) from human aorta
was used as positive control in
immunoblotting. Adhesion of
HUVEC onto confluent mono-
layers of E9, E15 and T3 clones
(B) was determined. Adhesion
is expressed relative to that
(arbitrarily taken as 100%) onto
E9. Data are given as
mean € SD from three inde-
pendent experiments, and the
asterisk indicates adhesion onto
T-cad-transfected cells is sig-
nificantly (P<0.01) less than
adhesion onto controls
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about 50% of adhesion onto control (empty vector-
transfected) L929 (Fig. 4B).
Discussion
In this study the cellular localisation of atypical GPI-
anchored T-cad in confluent and migrating human
endothelial and smooth muscle cells is demonstrated for
the first time, and we provide evidence that T-cad
functions in cellular deadhesion processes rather than
intercellular adhesion.
A first important observation was that expression
patterns for T-cad and classical VE-cadherin in confluent
monolayers of HUVEC were very different. VE-cadherin,
a specific endothelial protein responsible for formation of
intercellular contacts and control of vascular permeability
(Gory-Faure et al. 1999; Corada et al. 2001), was found,
as expected, at cell–cell junctions, while T-cad was
distributed globally, with only a slight enrichment at cell
borders. Similar global distribution patterns for T-cad
were found in confluent monolayers of SMC and also
carcinoma cell line ECV-304. These data imply that T-
cad is not required for maintenance of intercellular
adhesion.
A second striking observation was that T-cad redis-
tributes to the leading edge of migrating endothelial and
smooth muscle cells as well as ECV-304, thus invoking a
potentially important role for T-cad in directed locomo-
tion of cells. Polarisation of the cell body into the
protruding leading lamella and the retracting rear part
during directed migration is accompanied by asymmetric
distribution of specialised molecules between these
compartments. The leading edge contains chemokine
receptors and other signalling molecules that sense the
environment and induce localised actin polymerisation,
which is the basis of lamellopodia motility (Condliffe and
Hawkins 2000). Redistribution of T-cad to the leading
edge indicates some “recognition” function that might be
important for regulation of cell migration. These data
imply an interesting analogy with the embryonic nervous
system: in extending motor axons T-cad is localised at the
growth cones and acts as a repulsive navigation cue
inhibiting axon protrusion in the direction where contact
with another T-cad molecule on neighbouring cell was
established (Fredette and Ranscht 1994; Fredette et al.
1996). A possible function for T-cad as a repulsive cue is
supported by our observation that adhesion of HUVEC
onto a monolayer of T-cad-transfected L929 cells is
significantly less than adhesion onto control (T-cad-
negative) L929 cells. It is tempting to speculate that in
migrating vascular cells, T-cad, being a signalling and
sensing receptor, can also participate in recognition of
environmental cues and thereby influence cell behaviour.
The ability of atypical GPI-anchored T-cad to mediate
contact-dependent navigation of cell movements (Fredette
and Ranscht 1994; Fredette et al. 1996) might be
important for regulation of endothelial and smooth muscle
cell migration, and thereby vascular remodelling. More-
over, since cellular localisation of T-cad in confluent and
migrating cultures of ECV-304 carcinoma cells is the
same as vascular cells, contact-dependent navigation by
T-cad may represent a more general phenomenon in tissue
remodelling.
Thirdly, we show that caveolin is not directly involved
in T-cad-mediated signalling at the leading edge. GPI-
proteins, including T-cad (Philippova et al. 1998), and
other lipid-anchored membrane molecules are usually
associated with cholesterol- and glycosphingolipid-en-
riched raft membrane domains (Harder and Simons 1997).
Several raft-associated proteins have been shown to
accumulate preferentially at the leading lamella (Okada
et al. 1995), while raft disruption in cholesterol-depleted
cells inhibited cell polarisation and chemotaxis (Manes et
al. 1999). Hence, lipid rafts have been proposed to serve
as dynamic platforms for the selective delivery of
membrane proteins important for cell migration to the
leading edge (Gomez-Mouton et al. 2001). We have
previously suggested that putative signalling functions of
T-cad might be due to its direct physical interaction with
caveolar- and raft-associated signalling machinery
(Philippova et al. 1998). In examining this possibility
we do confirm a previous report of enrichment of
caveolin at the leading edge of migrating smooth muscle
cells (Okada et al. 1995), but not in endothelial cells.
Confocal analysis of migrating smooth muscle and
endothelial cells revealed colocalisation in the perinuclear
area but insignificant colocalisation of caveolin and T-cad
at the leading lamella. These data indicate that caveolin is
not involved in T-cad-mediated signalling at the leading
edge.
Taken together, our data on T-cad expression patterns
in vascular cells suggest that the ability of atypical GPI-
anchored T-cad to mediate contact-dependent navigation
of cell movements might be important for regulation of
endothelial and smooth muscle cell migration. This
supports the hypothesis on involvement of this molecule
in pathological vascular tissue remodelling associated
with abnormal vascular cell motility.
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